NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 149 filers reported holding NEKTAR THERAPEUTICS in Q2 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $905,656 | +6787.6% | 1,520,578 | +6552.0% | 0.00% | – |
| Q2 2023 | $13,149 | -99.5% | 22,859 | -94.8% | 0.00% | -100.0% |
| Q1 2022 | $2,392,000 | -61.7% | 443,800 | -4.0% | 0.01% | -64.0% |
| Q4 2021 | $6,246,000 | -34.0% | 462,300 | -12.3% | 0.02% | -40.5% |
| Q3 2021 | $9,467,000 | +3281.1% | 527,100 | +3262.0% | 0.04% | +2000.0% |
| Q1 2020 | $280,000 | -81.5% | 15,678 | -81.1% | 0.00% | -77.8% |
| Q3 2019 | $1,512,000 | -35.6% | 83,000 | +275.6% | 0.01% | -10.0% |
| Q1 2018 | $2,348,000 | +1748.8% | 22,100 | +140.2% | 0.01% | +900.0% |
| Q1 2016 | $127,000 | -56.9% | 9,200 | -47.4% | 0.00% | -50.0% |
| Q4 2015 | $295,000 | -80.4% | 17,500 | -87.3% | 0.00% | -83.3% |
| Q3 2015 | $1,507,000 | – | 137,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |